Franklin Resources’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.87M | Buy |
129,278
+37,409
| +41% | +$536K | ﹤0.01% | 1934 |
|
|
2025
Q4 | $1.31M | Buy |
91,869
+35,330
| +62% | +$347K | ﹤0.01% | 1968 |
|
|
2025
Q3 | $446K | Buy |
56,539
+21,544
| +62% | +$153K | ﹤0.01% | 2483 |
|
|
2025
Q2 | $201K | Buy |
34,995
+9,827
| +39% | +$63.4K | ﹤0.01% | 2752 |
|
|
2025
Q1 | $205K | Hold |
25,168
| – | – | ﹤0.01% | 2668 |
|
|
2024
Q4 | $237K | Sell |
25,168
-33
| -0.1% | -$343 | ﹤0.01% | 2597 |
|
|
2024
Q3 | $263K | Buy |
25,201
+252
| +1% | +$2.75K | ﹤0.01% | 2540 |
|
|
2024
Q2 | $247K | Buy |
24,949
+30
| +0.1% | +$308 | ﹤0.01% | 2497 |
|
|
2024
Q1 | $294K | Sell |
24,919
-30,024
| -55% | -$384K | ﹤0.01% | 2470 |
|
|
2023
Q4 | $780K | Buy |
54,943
+1,258
| +2% | +$14.3K | ﹤0.01% | 1749 |
|
|
2023
Q3 | $653K | Buy |
53,685
+2,163
| +4% | +$27.9K | ﹤0.01% | 1785 |
|
|
2023
Q2 | $647K | Buy |
+51,522
| New | +$611K | ﹤0.01% | 1849 |
|
|
2022
Q4 | – | Sell |
-12,277
| Closed | -$129K | – | 2354 |
|
|
2022
Q3 | $129K | Buy |
+12,277
| New | +$137K | ﹤0.01% | 2066 |
|
|
2020
Q1 | – | Sell |
-1,388,035
| Closed | -$13.5M | – | 1501 |
|
|
2019
Q4 | $13.5M | Sell |
1,388,035
-1,345,602
| -49% | -$12.3M | 0.01% | 835 |
|
|
2019
Q3 | $21.9M | Sell |
2,733,637
-75,791
| -3% | -$823K | 0.01% | 723 |
|
|
2019
Q2 | $35.1M | Sell |
2,809,428
-266,682
| -9% | -$3.38M | 0.02% | 628 |
|
|
2019
Q1 | $41.8M | Buy |
3,076,110
+10,504
| +0.3% | +$128K | 0.02% | 560 |
|
|
2018
Q4 | $29.4M | Sell |
3,065,606
-433,275
| -12% | -$4.76M | 0.02% | 612 |
|
|
2018
Q3 | $42.3M | Sell |
3,498,881
-536,552
| -13% | -$7.5M | 0.02% | 584 |
|
|
2018
Q2 | $63M | Buy |
4,035,433
+268,044
| +7% | +$4.05M | 0.03% | 474 |
|
|
2018
Q1 | $56.7M | Buy |
3,767,389
+48,490
| +1% | +$738K | 0.03% | 494 |
|
|
2017
Q4 | $53.5M | Buy |
3,718,899
+406,499
| +12% | +$5.58M | 0.03% | 517 |
|
|
2017
Q3 | $50M | Buy |
3,312,400
+1,426,100
| +76% | +$18.9M | 0.02% | 534 |
|
|
2017
Q2 | $19M | Hold |
1,886,300
| – | – | 0.01% | 805 |
|
|
2017
Q1 | $13.4M | Hold |
1,886,300
| – | – | 0.01% | 894 |
|
|
2016
Q4 | $9.38M | Sell |
1,886,300
-83,200
| -4% | -$576K | ﹤0.01% | 971 |
|
|
2016
Q3 | $14.6M | Hold |
1,969,500
| – | – | 0.01% | 882 |
|
|
2016
Q2 | $10.8M | Hold |
1,969,500
| – | – | 0.01% | 951 |
|
|
2016
Q1 | $16.6M | Hold |
1,969,500
| – | – | 0.01% | 850 |
|
|
2015
Q4 | $19.1M | Buy |
1,969,500
+763,600
| +63% | +$6.88M | 0.01% | 847 |
|
|
2015
Q3 | $16.9M | Sell |
1,205,900
-601,500
| -33% | -$9.43M | 0.01% | 894 |
|
|
2015
Q2 | $25.6M | Sell |
1,807,400
-147,000
| -8% | -$1.77M | 0.01% | 833 |
|
|
2015
Q1 | $21.3M | Hold |
1,954,400
| – | – | 0.01% | 877 |
|
|
2014
Q4 | $16.3M | Buy |
1,954,400
+81,300
| +4% | +$558K | 0.01% | 940 |
|
|
2014
Q3 | $11.1M | Buy |
+1,873,100
| New | +$9.81M | 0.01% | 1024 |
|
Other funds holding FOLD
VCM
PCM
VPM
GCL
Franklin Resources's FOLD Position: Q1 2026 in Review
Franklin Resources increased its Amicus Therapeutics (FOLD) stake by 41% in Q1 2026, buying an estimated $536K and bringing the position to 129,278 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1934.
Franklin Resources first reported a position in FOLD in Q3 2014 and has held it in 35 quarters since. The position peaked at $63M in Q2 2018. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- Franklin Resources held 129,278 shares of Amicus Therapeutics worth $1.87M as of Q1 2026.
- Franklin Resources bought 37,409 Amicus Therapeutics shares in Q1 2026, an estimated $536K.
- Amicus Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #1934 holding.
- Franklin Resources first reported a position in Amicus Therapeutics in Q3 2014 and has held it in 35 quarters since.
- Franklin Resources's Amicus Therapeutics position peaked at $63M in Q2 2018.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.